XFOR
NASDAQ
$3.68
X4 Pharmaceuticals Inc (XFOR)
X4 Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the research, development, and commercialization of new therapies for the treatment of back diseases. The company is headquartered in Boston, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $11.60 (+215.22%)
Market Cap
$368M
Free Cash Flow Yield
-25.24%
Beta (5Y)
1.50
Price Chart
Valuation
Market Cap$368M
P/S40.81
P/B2.25
Profitability
Total Revenue (TTM)$9.01M
Gross Profit (TTM)$7.38M
EBITDA-$97M
Operating Margin-748%
EPS-$4.90
Financial Health
Debt-to-Equity44.5%
Free Cash Flow Yield-25.24%
Growth & Risk
FCF 5Y CAGR+8.50%
Beta (5Y)1.50
Sharpe Ratio1.22